grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
Published 2 years ago • 63 plays • Length 21:58Download video MP4
Download video MP3
Similar videos
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
20:32
grace targeted therapies lung cancer 2021 - ros current therapies, emerging treatment options
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
2:07
grace targeted therapies lung cancer 2021 - ros1 & alk treatments transform neuroendocrine tumor
-
11:49
grace targeted therapies lung cancer 2021 - online communities, education & partnership in research
-
2:39
grace targeted therapies lung cancer 2021 - return to alectinib -progression on lorlatinib in alk
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
17:53
grace targeted therapies lung cancer 2021 - genotype directed therapy: role in earlier stage disease
-
4:06
grace targeted therapies lung cancer 2021 options after progression on alectinib?
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2
-
14:57
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 1
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
17:40
liquid biopsies: current applications - grace targeted therapies in lung cancer patient forum 2021
-
4:02
grace targeted therapies in lung cancer 2021 - future, telemedicine & interstate treatment
-
4:55
evolution of therapy in lung cancer - 2022 program: targeted therapies forum
-
3:29
grace targeted therapies lung cancer 2021 - can a patient have multiple mutations & how to treat?